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1. Introduction 
Surface micro-topography has been shown to modulate cell adhesion and cell 
morphology (1), a phenomenon known as contact guidance (2-4). This effect is correlated 
with changes in gene (5) and protein expression (6). The use of micro-topography to 
modulate cell morphology, gene expression, protein expression, cell proliferation and cell 
differentiation has been applied to many studies aiming at tissue regeneration (7-9). 
Polycaprolactone (PCL) has been used widely in regenerative medicine because it is 
biocompatible and FDA approved. Furthermore, the imprinting of topographic features in 
the surface of PCL sheets is highly reproducible (10). Since PCL degrades with time post 
implantation (11), it presents an opportunity for gradual drug release (12).  
 
In this study the integration of alternative medicine was applied to the grooved PCL 
sheets to observe the modulation of cell phenotype. The use of drug-impregnated 
composite biomaterials has been previously studied with various active agents, including 
bone morphogenic protein (13) and the antibiotics vancomycin (14) and tetracycline (15). 
In this study we focused on the use of a Chinese herb, Puerariae radix (the root of 
Pueraria lobata and Pueraria mirifica plants). This traditional Chinese medicine has 
been used for the treatment of various diseases and to promote bone healing for millenia 
and recent data suggest beneficial activity (16-20). The active ingredients have been 
identified as the isoflavones: puerarin, daidzin and daidzein, which have estrogenic 
activity (21-24). Puerariae radix has shown positive therapeutic effects in animal studies 
(25-27) and in cell culture studies, Puerariae radix was shown to induce osteogenic 
activity (20, 28-31). The studies showed that Puerariae radix had no effect on viability, 
but enhanced Alkaline phosphatase (ALP activity), vascular endothelial growth factor 
(VEGF), bone matrix proteins such as osteocalcin (OCN), osteopontin (OPN), and 
collagen type I, and mineralization (20). A more detailed study using primary rat 
osteoblasts showed that puerarin caused a significant increase in cell viability, alkaline 
phosphatase (ALP) activity and mineral nodule formation by stimulating osteoblastic 
proliferation and activation of Akt in a phosphatidylinositol 3-kinase (PI3K)-dependent 
manner (30). 
 
This report describes studies of Puerariae radix activity in composited polymers which 
could be applied in the field of tissue engineering. The puerariae powder was pressed into 
the melted PCL and the other side of the PCL was imprinted with micro-grooved 
features. This provided a bilayer material from which the active ingredients were 
expected to be gradually released from the PCL into the culture medium. 
 
Differential In Gel Electrophoresis (DIGE) was exploited to compare the proteomic 
changes that are effected in response to surface topography and surface topography 
combined with Peurariae radix powder.  
 
In this study, primary human STRO-1+ skeletal stem cells were used. The STRO-1+ 
population of human bone marrow is capable of osteogenic differentiation as well as 
reticular, chondrogenic and adipogenic differentiation (32, 33). These cells were 
separated from adult human bone marrow stromal cells (BMSCs) by the monoclonal 
antibody (MAb) STRO-1, which recognizes a trypsin-resistant cell surface antigen 
present on a subpopulation of bone and marrow cells (34).  
 
2. Materials and Methods 
 
2.1 Material Fabrication 
Quartz slides were cleaned in 7 parts Sulphuric acid and 1 part hydrogen peroxide for 5 
mins. The slides were then spincoated with AZ primer at 4000 rpm for 30 secs. Shipley 
S1818 photoresist was next added, and the slides were spun for a further 30 secs. After 
spinning, the slides were soft baked at 90oC for 30 mins. The samples were then exposed 
to uv light through a chrome mask (Hoya), patterned with 12.5µm wide line pattern. The 
exposed resist was developed using 1:1 (v/v) Shipley AZ developer: water. The slides 
were next etched to produce 2 µm deep grooves in a Plasma Technology RIE80 unit (Tri-
chloromethane environment, pressure of 15 mTorr (1 Torr = 133.322 Pa), R.F. power of 
100W, giving an etch rate of 25 nm/min). The mastering resist was then removed and the 
whole slide was etched for a further minute to produce a uniform chemistry. The 
fabricated slide has 12.5 μm width and 2 μm depth micro-grooved topography. 
 
Cleaned polycaprolactone (PCL; Sigma-aldrich) sheet was melted then puerariae powder 
(purchased from Jishou City, Hunan province, China) was randomly spread onto the 
surface of the melted PCL at ratios 0, 1 and 2% w/w and then pressed with plain glass 
slide to impregnate puerariae powder into the melted PCL. The composite PCL sheet was 
cooled down then the glass slide was separated. For embossing, the PCL sheet was cut 
into 2 cm2 squares before being cleaned with 75% ethanol following by deionized water 
and blown to dry with cool air. The powder-free top side was embossed as describe in our 
previous study (6). Briefly, the PCL substrates were heated until they started to melt. 
Either the grooved or planar quartz slides were embossed onto the PCL substrates. PCL 
substrates were cooled down and the glass slides were removed. 
 
2.2 Cell culture 
Human bone marrow stromal cells were obtained from hematologically normal patients 
undergoing routine surgery. Only tissue that would have been discarded was used with 
the approval of the Southampton & South West Hants Local Research Ethics Committee. 
Primary cultures of bone marrow cells were established as previously described (35). The 
STRO-1+ fraction was isolated according to the method described by Howard et al (36). 
 
STRO-1+ cells (2nd passage) were cultured in 75 cm2 tissue culture flasks. Culture was 
maintained in basal media (α-MEM containing 10% FBS and 2% antibiotics) at 37 0C, 
supplemented with 5% CO2. Confluent cell sheets were trypsinized and 1x105 cells were 
seeded onto 2 cm2 PCL sheets with different features as following: 1) flat PCL, 2) micro-
groove PCL, 3) micro-groove PCL with 1% puerariae powder and 4) micro-groove PCL 
with 2% puerariae powder. Materials were cultured in basal medium and maintained in 
culture with 5% CO2 at 37 oC for 5 weeks. Medium was changed twice a week.  
 
 
 
 
2.3 Toxicity and Cell Morphology 
After 5 weeks, cell morphology and cell survival were observed by Coomassie staining. 
PCL sheets with cultured cells were fixed in 4% formaldehyde in PBS for 5 minutes. Cell 
staining was performed using 5% Coomassie blue in 40% methanol and 10% acetic acid 
for 5 minutes. The stained materials were washed twice in tap water. Pictures were taken 
by greyscale digital camera (Scion Corporation Model CFW-1310M). 
2.4 Osteocalcin Staining 
After 3 weeks of culture, the cells on the test materials were fixed in 4% formaldehyde in 
PBS, with 1% sucrose at 37°C for 15 min. When fixed, the samples were washed with 
PBS, and a permeabilizing buffer (10.3 g sucrose, 0.292 g NaCl, 0.06 g MgCl2, 0.476 g 
Hepes buffer, 0.5 ml Triton X, in 100 ml water, pH 7.2) was added at 4 °C for 5 min. The 
samples were then incubated at 37 °C for 5 min in 1% BSA in PBS, followed by the 
addition of an anti-osteocalcin primary antibody (1:50 in 1% BSA in PBS, osteocalcin 
monoclonal anti-human raised in mouse (IgG), Autogen Bioclear, UK) for 1 h (37 °C). 
Simultaneously, rhodamine conjugated phalloidin was added for the duration of this 
incubation (1:100 in 1% BSA in PBS, Molecular Probes, Oregon, USA). The samples 
were next washed in 0.5% Tween 20 in PBS (5 min×3). A secondary, biotin conjugated 
antibody, (1:50 in 1% BSA in PBS, monoclonal horse anti-mouse (IgG), Vector 
Laboratories, Peterborough, UK) was added for 1 h (37 °C) followed by washing. A 
FITC conjugated streptavidin third layer was added (1:50 in 1% BSA in PBS, Vector 
Laboratories, Peterborough, UK) at 4 °C for 30 min, and a final wash was performed. 
Samples were then viewed by fluorescence microscope (Zeiss Axiovert 200 m). 
 2.5 Differential In Gel Electrophoresis 
Two groups of experiment were set. First, the control group which protein extracts from 
flat PCL sheets were run against protein extracts from grooved PCL sheets. Second, the 
test group which protein extracts from flat PCL sheets were run against protein extracts 
from 2% w/w puerariae powder-impregnated PCL sheets as suggested in figure 1. 
 
1) Protein Extraction: After 5 weeks culture, cell layer on PCL sheet were lysed in 1 ml 
of DIGE lysis buffer (7M Urea, 2M Thiourea, 4% CHAPS and 30 mM Tris-base pH 8.0) 
with 1X final concentration of general purposes protease inhibitor cocktail (Sigma-
Aldrich). The cell suspension was left at room temperature for 1 hour with vigorous 
mixing every 20 minutes. The PCL sheets were taken out and the suspension was then 
centrifuged at 2,100 rpm for 10 minutes to remove insoluble material. Proteins were then 
precipitated from the supernatant by addition of 4 volumes of 100% cold acetone. After 
centrifugation, the protein pellets were washed in 80% acetone and re-suspended in DIGE 
lysis buffer. The Bradford protein assay was used to determine the amount of protein 
extracted from each material. Briefly, varying concentrations of BSA (50, 25, 12.5, 6.25 
and 3.125 μg/ml) were prepared and used as a standard curve. 10 μl of each standard and 
sample was mixed with 200 μl of protein assay reagent (Bio-Rad). The reaction was left 
to progress at room temperature for 5 minutes. Absorbance was measured at 595 nm. 
Protein concentrations of the protein extracts from the test materials were determined 
from the standard curve. 
 
2) Saturation labelling: 5 μg of the extracted proteins were added into sterile microfuge 
tubes. Protein in each tube was reduced with 1 μl of 2 mM TCEP. The reactions were 
incubated at 370C in the dark for 1 hour. Protein in each tube was labeled with the 
required volumes (2 μl) of Cy3 and Cy5 in the dark for 30 minutes (Typically, 5 μg of 
protein requires 2 nmol TCEP and 4 nmol of CyDye). Equal volumes of 2X sample 
buffer (7M Urea, 2M Thiourea, 4% w/v CHAPS, 2% w/v IPG buffer pH 4-7 and 2% w/v 
DTT) were added to stop the reactions. Proteins labeled with Cy3 and Cy5 were mixed 
together. 2D-Gel electrophoresis was performed. 
 
3) 2D-Gel Electrophoresis: First dimension isoelectric focusing (IEF) was performed on 
IPG strips (24 cm; linear gradient pH 4–7) using an Ettan IPGphor system (GE-
Healthcare). IEF was performed using the following voltage program: 30 V constant for 
12 h, 300 V constant for 1 h, linear up to 600 V over 1 h, linear up to 1,000 V over 1 h, 
linear up to 8,000 V over 3 h, then 8,000 V constant for 8.30 h. The current was limited 
to 50 μA per strip and the temperature maintained at 20 0C. After focusing, strips were 
equilibrated for 15 min in 5 ml of reducing solution (6 M urea, 100 mM Tris-HCl pH 8, 
30% v/v glycerol, 2% w/v SDS, 5 mg/mL DTT). For second dimension SDS-PAGE, IPG 
strips were placed on the top of 12% acrylamide gels cast in low fluorescence glass plates 
and then sealed by 0.5% (w/v) agarose overlay solution. Gels were run at constant power 
50 W/gel until the bromophenol blue tracking front had reached the base of the gel. 
Fluorescence images of the gels were obtained by scanning on a Typhoon 9400 scanner 
(GE Healthcare). Cy3 and Cy5 images were scanned at 532 nm/580 nm and 633 nm/670 
nm excitation/emission wavelengths respectively, at a 100 mm resolution. Image analysis 
and statistical quantification of relative protein expression was performed using 
DeCyderTM 7 software (GE Healthcare). 
  
4) Preparative 2D gel: 500 μg protein extracted from human STRO-1+ cultured in a 
tissue culture flask was reduced by 10 μl of 20 mM TCEP and then labeled with 10 μl of 
20 mM Cy3 DIGE flour. After this, 2D-Gel Electrophoresis was performed and the gel 
scanned as described above. The preparative gel image was matched with analytical 
DIGE gel images and the spots of interest were selected for further analysis. A pick list 
was generated, containing gel co-ordinates that were used to direct spot cutting for spots 
of interest. Gel spots were excised using an Ettan Spot Handling Workstation (Amersham 
Biosciences, UK) and each gel piece was placed in a separate well of a 96-well plate. Gel 
pieces were washed three times in 100 μl of 50 mM ammonium bicarbonate, 50% v/v 
methanol and then twice in 100 μl 75% v/v acetonitrile, before drying. Gel pieces were 
rehydrated with trypsin solution (20 μg trypsin/ml 20 mM ammonium bicarbonate), and 
incubated for 4 h at 37 oC. Peptides were extracted from the gel pieces by washing twice 
in 100 μl of 50% v/v acetonitrile / 0.1% v/v trifluoroacetic acid, before being transferred 
in solution to a fresh 96 well plate and dried before mass spectrometric (MS) analysis.  
5) MS/MS and Database Analysis. Tryptic peptide solutions were mixed at a 1:1 ratio 
with 5 mg/mL α–cyano-4-hydroxycinnamic acid (CHCA) matrix in 0.3% TFA, and 
spotted on stainless steel MALDI sample plates (Applied Biosystems, Framingham, MA). 
Peptide mixtures were then analyzed using MALDI/TOF/TOF (4700 Proteomics 
Analyzer, Applied Biosystems, Framingham, MA). MALDI-TOF spectra were collected 
from m/z 800 – 4000 and up to 10 peaks were selected for MS/MS analysis. Protein 
identification was performed using Global Proteome Server Explorer software (Applied 
Biosystems, Framingham, MA) utilizing the NCBI Reference Sequence human protein 
database. The identification was assigned to a protein spot feature if the protein score was 
calculated to be greater than 50, correlating to a confidence interval of 95%. Protein 
identifications were assigned using the Mascot search engine, which gives each protein a 
probability based MOWSE score. In all cases variable methionine oxidation was used for 
searches. Only proteins identified with a significant score (p = <0.05) were included, 
corresponding to a MOWSE score greater than 66. 
 
2.6 HPLC detection of isoflavone in growth media 
For standard, 130 mg of puerariae powder was dissolved in 2 ml of distilled water and 
mixed vigorously for 30 minutes before 6 ml of methanol was added. The solution was 
left at room temperature for 1 hour with vigorously mixing every 20 minutes. Powder 
solution was spun down at 2100 rpm for 20 min. Supernatant was collected and aliquoted 
into eppendorf tubes for 1 ml/vial. All vials were dried by speed vacuum centrifugation. 
For culture medium, PCL sheets (with or without powder) were incubated with 2 ml 
medium at 37 oC for 2 weeks. 2 ml of medium was collected and 6 ml of methanol was 
added and processed with the same procedure for standard. 
 
200 μl methanol was added to a dried standard vial and 50 μl methanol was added to a 
dried sample vial, due to the anticipated reduction in concentration of the active 
ingredient, 10 μl of each sample was used to perform the reversed phase separation. 
Reversed phase HPLC was performed as described in Jiang et al (37). Briefly, buffers 
consisted of 0.2% acetic acid (A) and acetonitrile (B). The gradient consisted of a 10 
minute isocratic at 15% B, followed by a linear gradient from 15% to 30% B in 2.5 
minutes, an isocratic at 30% B for 10 minutes, a linear gradient from 30% B to 15% B in 
2.5 minutes, and finally an isocratic at 15% B for 5 minutes. The HPLC system used was 
an UltiMate (Dionex) running at 200 μl/min with a 4.6mm x 25cm C18 reversed phase 
column (Phenomenex). Detection was performed using an UltiMate UV absorbance 
detector at a wavelength of 254 nm. 
 
2.7 The Mass Identification of isoflavones in crude extract  
The preparation of DHB and sample was modified from (38): the matrix solution 
contained 10−15 mg/mL DHB in 10% ethanol. The ratio of matrix solution to clude 
extracts was 1:1. The mixture (1.5 μL) was applied to a MALDI-TOF MS plate and air-
dried.  
3. Results 
3.1 Atomic Force Microscopy 
The AFM images (figure 2) showed that the grooved topography from quartz slide was 
successfully embossed onto the PCL sheet. Furthermore, the images indicate that herbal 
particles at the bottom side of PCL sheets did not affect the surface topography. The 
surface roughness of the control PCL sheet was evaluated and the typical Ra was 28.406. 
 
3.2 Cell morphology and Toxicity 
Coomassie blue staining after 5 weeks indicated that human STRO-1+ cells on the flat 
control were observed to be well spread whilst STRO-1+ cells on all micro-grooved PCL 
were contact guided along the grooved direction (figure 3). Confluent cell layers (90%+) 
were observed on control, grooved PCL, 1% w/w puerariae powder-impregnated grooved 
PCL and 2% w/w puerariae powder-impregnated grooved PCL. This result indicates that 
the puerariae powder at concentrations of 1 and 2% w/w did not affect cell growth and 
cell viability. Thus, only 2% w/w puerariae powder-impregnated grooved PCL was 
chosen to use in the subsequent experiments. 
 
3.3 Osteocalcin staining 
Osteocalcin staining was performed after 3 weeks culture on control flat PCL sheet, 
grooved PCL and 2% w/w puerariae powder-impregnated grooved PCL (figure 4). 
Osteocalcin expression was not observed on control PCL whilst weak expression was 
observed on grooved PCL. Positive osteocalcin was clearly observed in cells cultured on 
2% w/w grooved puerariae powder-impregnated sheets (figure 4C). 
  
3.4 Differential In Gel Electrophoresis (DIGE) 
DIGE results showed that the expression of a number of proteins (figure 5) was 
significantly modulated following the culture of human STRO-1+ cells on micro-grooved 
PCL (with/without puerariae powder), in comparison to STRO-1+ cells cultured on flat 
control as a standard. A list of proteins that showed modulated expression upon exposure 
to 2% w/w puerariae powder-impregnated grooved PCL compared against grooved PCL 
are presented in table 1.  
 
Protein descriptions 
1. Gelsolin: Gelsolin was down-regulated in all three gels of the test group when 
compared to the control group. Gelsolin is an actin-binding protein that nucleates actin 
polymerization and severs and caps actin filaments in a calcium dependent manner (39). 
Under depolymerizing conditions, these gelsolin-capped ends allow the disassembly of 
populations of actin filaments by subunit loss from the pointed ends. Under polymerizing 
conditions, gelsolin exhibits calcium-dependent actin nucleating activity and stimulates 
actin filament formation from monomers (40). 
2. Tubulin: Tubulin was down-regulated in the test group when compared to the control 
group. Previous studies have demonstrated a correlation between the state of organization 
and the expression of the respective cytoskeletal protein by showing that 
depolymerization of microtubules leads to a rapid decrease in new tubulin synthesis (41). 
Non-polymerized tubulin represses its own synthesis (42). Microtubule depolymerization 
induces mitotic arrest and suppresses tumor cell growth (43). 
3. Vinculin: Vinculin was up-regulated only in the test group when compared to the 
control group. Vinculin is a major component of adhesion plaques and cell-cell junctions. 
The existence of a coordinated mechanism(s) of actin polymerization-dependent 
regulation of actin and vinculin synthesis was suggested by previous study (44). A 
stabilizer of polymerized actin that increased the level of assembled actin, resulted in 
elevated vinculin synthesis (44). 
4. Vimentin: Vimentin was up-regulated on grooved-materials and 2% puerariae powder 
impregnated-grooved PCL. The expression of vimentin in the test group was 
approximately 12-times higher compared to the control group. Vimentin and intermediate 
filaments were also used as a differentiation marker in a number of cell types. The 
differentiation process of optic vesicle epithelium into neural retina is influenced by the 
amount of vimentin in epithelial cells (45). In the clonal osteoblast-like cell line MC3T3-
E1, cDNAs of vimentin were up-regulated in differentiation compared with proliferation 
(46). Vimentin expression could thus play a role at an advanced stage of skeletal stem 
cell differentiation (47).  
5. Actin: Actin and profilin-beta-actin were up-regulated in all three gels of the test group 
in comparison to the control group. Previous studies suggested that increased actin 
polymerization resulted in smooth muscle cell differentiation and increased actin 
expression (48). Actin assembly is regulated by controlling the balance between 
polymerized and non-polymerized actin and stabilization of polymerized actin results in a 
significant increase in actin synthesis (44). 
6. Laminin binding protein (Laminin receptor): Laminin receptor was up-regulated in 
the test group when compared to the control group. Estrogen decreases laminin 
expression (49). However, Laminin-111 suppress the expression of estrogen receptor 
(ERbeta1) at the mRNA level (50). Laminin binding to its receptors acts via 
phosphatidylinositol-3-kinase/Akt (PI3K/Akt)(51, 52), as does estrogen and 
phytoestrogen (30, 53, 54). The augmentation of laminin receptor mRNA by estrogen and 
progesterone treatment in hormone receptor-positive human breast cancer cell lines has 
been reported (55). 
7. Annexin V (AnxV): Annexin V was up-regulated in two gels of the test group when 
compared to the control group. AnxV is a calcium-dependent phospholipid binding 
protein which functions as a Ca2+ selective ion channel. Annexin V has the ability to 
interact with both extracellular matrix proteins and cytoskeletal elements. Overexpression 
of annexin V also resulted in up-regulation of osteocalcin (56).  
8. Cofilin: Cofilin was up-regulated only in the test group. Cofilin expression and 
phospho-cofilin were strongly increased cell culture conditions favoring myofibroblast 
differentiation (57). Cofilin is phosphorylated at serine 3 by LIM domain kinase (LIMK) 
and Testis-specific kinase (TESK) and that inhibits cofilin binding to F-actin, leading to 
F-actin stabilization. Cofilin dephosphorylation by slingshot (SSH) and chronophin (CIN) 
stimulates F-actin depolymerization and severing (58). 
9. Myosin head domain containing protein: Myosin head functions through its ATPase 
reaction as a force generator and as a mechanosensor, and two myosin heads work 
together in moving along an actin filament which is involved in a wide range of transport 
and contractile activities in cells (59, 60). 
3.5 HPLC detection of isoflavone in growth media 
Herein, the reported peaks were, in general, broader than those described in previous 
studies (37), probably as a consequence of the decreased flow-rate used. However, a 
strong doublet corresponding to an isoflavone/unknown pair is seen at the same retention 
time, and possessing equivalent peak area to that described in the Jiang paper (37). Figure 
6 shows typical chromatograms consisting of a) the puerariae standard, b) serum-free 
growth medium control, c) serum-free growth medium from puerariae-impregnated 
grooved-PCL, d) serum-containing growth medium control e) serum-containing growth 
medium from puerariae-impregnated grooved-PCL. 
 
The isoflavone doublet can clearly be observed as a pair of slightly broad, low intensity 
peaks corresponding exactly in retention time and relative abundance to the standard in 
the serum-free growth medium from puerariae-impregnated grooved-PCL, where as it is 
unobserved in both control samples. The isoflavone peak does not appear in the serum-
containing growth medium from impregnated grooved-PCL, but this is likely to be a 
consequence of the reduced abundance (50%) of the compound in comparison to serum-
free medium sample.  
 
 
 
3.6 Mass spectrometry of the crude extract 
The mass spectrum of the crude extract showed 3 major peaks of 413.2102, 417.0634 and 
429.1615 (figure 8). Data from Massbank records indicates that the negative ionization 
mass spectrum of puerarin is 415.1004 (M-H)- whilst the positive ionization mass 
spectrum is 417.1180 (M+H)+ and the exact mass is 416.11073 (by LC-ESI-IT-TOF-
MS). This study found a peak at 417.0634 (by MALDI-TOF), which is closed to the 
positive ionization mass spectrum (417.1180) from the Massbank record. 
 
Discussion 
Coomassie staining indicated that cell growth and cell survival on flat PCL, grooved-
PCL, 1% puerariae powder impregnated-grooved-PCL and 2% puerariae powder 
impregnated-grooved-PCL were similar. Hence the 2% puerariae powder impregnated-
grooved-PCL was chosen to compare against grooved-PCL using flat surfaces as a 
standard to study the integrated effect between isoflavones and topographical contact 
guidance. The study was separated into two groups (figure 1). Along with the test group 
(in which 2% puerariae powder impregnated-grooved-PCL was run against flat PCL), the 
control group (in which normal grooved PCL was run against flat PCL) was used to 
provide the fundamental effect of cell contact guidance on the skeletal stem cells.  
 
Puerariae radix (PR) is a popular natural herb and a traditional food in China. Isoflavones 
are a subclass of flavonoids. Isoflavones such as puerarin, daidzin, and daidzein are 
commonly regarded as phytoestrogens found in PR owing to their estrogenic activity in 
certain animal models (61, 62). Results from cell cycle distribution indicated that 
isoflavones from puerariae radix mediated cell cycle arrest in the G2/M phase (63). The 
study of estrogen (17β-Estradiol) treatment on osteoblastic MBA-15 cells derived from 
marrow stromal origin resulted in reduction in expression of tubulin (64) as found in this 
study (7-fold). These previous studies suggested the report of tubulin down-regulation in 
this study, as cell cycle arrest in the G2/M can result in the depolymerization of 
microtubules to tubulin monomer which suppresses its own synthesis, can result in cell 
differentiation. 
 
Up-regulation of vimentin was even stronger on impregnated-grooved-PCL (12 fold 
compared to control) (table 1) which might indicated an advanced stage of differentiation 
(47). These results may indicate that the impregnated-grooved-PCL caused cell cycle 
arrested and induced differentiation. 
 
Down-regulation of gelsolin and up-regulation actin together with annexin V were seen 
on 2% puerariae powder impregnated-grooved-PCL when compared to grooved PCL. 
These results indicated dynamic polymerizing condition of actin which happened in 
differentiation state (65) and because gelsolin works in a  calcium-dependent manner (39) 
thus this event supported the up-regulation of annexin V. Furthermore, up-regulation of 
annexin V was related with the up-regulation of osteocalcin in the cultured cells (56) 
which was supported by osteocalcin staining. However, changes in expressions of these 
proteins were not significant.  It was likely that dynamic polymerizing condition of actin 
and differentiation of the cultured cells were also observed on normal grooved-PCL (6, 
66) which could be observed by the modest osteocalcin staining (figure 4B). 
At 3 weeks, osteocalcin staining for bone extracellular matrix indicated that 2% puerariae 
powder impregnated-grooved-PCL inserted stronger effect for osteocalcin production 
when compared to normal micro-grooved PCL and flat PCL which indicated that the 
impregnated-grooved-PCL modulated phenotypic change in the cultured cells. 
 
We postulate that whilst the microgrooves clearly had effects on the proteome and 
contact guidance of STRO-1+ cells, it is possible that more fibroblastic differentiation 
was induced. Fibroblasts adopt a biopolarised, contact guided morphology in vivo. The 
cells on the grooves are reminiscent of such a natural morphology. This is somewhat 
contrast with initial consideration in our previous study where unselected osteoprogenitor 
cells of the bone marrow were shown to form mineral nodules on microgrooves (6). 
However, it must be noted that unselected human bone marrow is a heterogeneous 
population that contains cells already committed to the osteoblast lineage, and indeed, 
mature osteobalsts. The STRO-1+ selected skeletal stem cells, however, enriched of 
osteoprogenetors and represent an earlier bone cell population. Puerariae powder and 
micro-grooved topography clearly modulated the skeletal cell proteome which indicated 
that on the surfaces cells were differentiating. However, from the protein expression 
profile and the histologic analysis, it was unclear which cells predominated on the 
surfaces.  Since human STRO-1+ population are capable of osteogenic differentiation as 
well as reticular, chondrogenic and adipogenic differentiation. Additionally, the herb 
itself has a broad-effect on cell differentiation i.e. neurogenic has been suggested by 
others (67) and osteogenic differentiation (20).  Furthermore, previous studies have also 
indicated that activation of a focal adhesion kinase (FAK) and extracellular signal-related 
kinase (ERK) dependent pathway by laminin binding to LG3 integrin binding domain 
mediated osteogenic differentiation but did not increase matrix mineralization, 
demonstrating that the activation of FAK and ERK signaling is not sufficient to induce 
complete osteogenic differentiation in vitro (68). A previous study indicated that 
phytoestrogen, puerarin, act via phosphatidylinositol-3-kinase/Akt (PI3K/Akt) (54) thus 
complete osteogenic differentiation might need more than one signaling pathway working 
in concert with each other. In this study even the osteocalcin staining was positive at 3 
weeks but the study of the effect of puerariae radix on bone tissue engineering might need 
partial committed like unselected osteoprogenitor cells. 
 
The combination of micro-grooved substrate topography and puerariae powder appears to 
exert a significant effect on skeletal stem cells beyond the topographical cues stimulating 
the skeletal stem cells to change their proteomic regulation. Nevertheless, there is a need 
to study the effects of puerariae powder and topographical cues using unselected 
osteoprogenitors to provide heterogeneous populations. Such studies allow examination 
of the in vivo scenario and can be informative in delineating cell selection/differentiation 
strategies. 
 
Conclusions 
Topographical cues together with impregnated-puerariae powder induced changes in the 
skeletal stem cell proteome. The use of liquid chromatography and mass spectrometry 
indicated that the active ingredients in puerariae powder were released into the culture 
medium. This study suggests an alternative approach using puerariae powder in materials 
research and the potential therein for such approaches to modulate cell phenotype and 
function. 
Legends 
Figure 1. Working diagram: This diagram presented that DIGE experiment was 
separated into control group and test group. The control group provided the fundamental 
effect of micro-groove topography whilst the test group provided the integration effect of 
micro-groove topography and puerariae powder.  
 
Figure 2. The Atomic Force Microscope analysis: (A) control flat PCL sheet, (B) 
grooved PCL, (C) 1% w/w puerariae powder-impregnated grooved PCL and (D) 2% w/w 
puerariae powder-impregnated grooved PCL. 
 
Figure 3. Cell morphology: (A) control flat PCL sheet, (B) grooved PCL, (C) 1% w/w 
puerariae powder-impregnated grooved PCL and (D) 2% w/w puerariae powder-
impregnated grooved PCL. Confluent cell layers (90%+) were observed on all materials. 
Puerariae powder at concentrations of 1 (C) and 2% (D) w/w did not affect cell growth 
and cell survival. 
 
Figure 4. Osteocalcin staining: (A) control flat PCL sheet, (B) grooved PCL, (C) 2% 
w/w puerariae powder-impregnated grooved PCL. No positive osteocalcin staining was 
observed on flat PCL whilst slight positive result (small green spots) was found on 
grooved PCL. Strong positive osteocalcin was clearly observed on 2% w/w puerariae 
powder-impregnated grooved PCL (green spots). 
 
 
Figure 5. DIGE analysis: Protein spots with changed expression were presented on 
DIGE preparative gel image. The numbers represented proteins with changes in their 
expression i.e. 1. gelsolin, 2. tubulin, 3. vinculin, 4. vimentin, 5. actin, 6. Laminin- 
binding protein, 7 annexin V, 8. cofilin and 9. myosin head domain containing protein.  
 
Figure 6. HPLC detection of isoflavones at 254nm: Black lines denote UV absorbance 
chromatograms. Samples consist of a) puerariae standard, b) serum-free medium control, 
c) serum-free medium with puerariae powder-impregnated micro-grooved PCL d) serum-
containing medium control, e) serum-containing medium with puerariae powder-
impregnated micro-grooved PCL. Isoflavones is the first peak in the doublet (circled with 
red in (a)), and is clearly visible, but low abundance (circled in blue) in (c). 
 
Figure 7. Mass Spectrum of isoflavones in clued extract: Isoflavones peak at 417.0634 
m/z was detected by MALDI-TOF-TOF.  
 
Table 1. Protein expression profiles: protein expression profiles of cells cultured on 2% 
puerariae powder impregnated-grooved PCL were compared against grooved PCL sheets 
using protein extract from flat PCL as a standard. Three replicates of DIGE analysis were 
performed. Average volume (AV) ratios of protein expression together with p-values 
were presented. Note that p-values > 0.05 were marked with *. 
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No. 
 
Proteins 
 
AV ratio 
 
p-value 
  
1 Gelsolin -1.55 0.17* 
2 Tubulin -7.63 0.0024 
3 Vinculin 3.02 0.018 
4 Vimentin 12.46 0.0025 
5 Actin 2.02 0.48* 
6 Laminin binding 
protein 
4.59 0.020 
7 Annexin V 1.89 0.28* 
8 Cofilin 5.39 0.015 
9 Myosin head domain 
containing protein 
-1.55 0.042 
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